Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

37.55
Delayed Data
As of 4:02pm ET
 -0.14 / -0.37%
Today’s Change
37.20
Today|||52-Week Range
45.58
-5.61%
Year-to-Date
Asset Sales, New Projects Fuel 6.7% Yield
10:18am / GuruFocus News - Paid Partner Content
Merck's Keytruda Gets Priority Review for Hodgkin Lymphoma
Dec 02 / Zacks.com - Paid Partner Content
Pfizer Takes $106 Million Fine from U.K. for Price Hike of Epilepsy Drug
6:39am / TheStreet.com - Paid Partner Content
Jeff Auxier Curbs Multiple Positions in 3rd Quarter
Dec 01 / GuruFocus News - Paid Partner Content
Has GlaxoSmithKline Finally Turned the Corner?
Dec 06 / MotleyFool.com - Paid Partner Content
Here's the Best Dividend Stock in Big Pharma
Dec 01 / MotleyFool.com - Paid Partner Content
Robust Pipeline Supports 5.5% Dividend Yield
Dec 05 / GuruFocus News - Paid Partner Content
Merck: Keytruda's Priority Review for New Cancer Indication
Nov 29 / Zacks.com - Paid Partner Content
How to Buy GlaxoSmithKline at a 15% Discount
Dec 02 / TheStreet.com - Paid Partner Content
Glaxo (GSK) Files Regulatory Application for Shingrix in EU
Nov 28 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close37.69
Today’s open37.47
Day’s range37.20 - 37.63
Volume4,975,806
Average volume (3 months)3,261,560
Market cap$91.9B
Dividend yield5.56%
Data as of 4:02pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+10.59%
Earnings growth (next 5 years)+13.26%
Revenue growth (last year)-3.66%
P/E ratio335.3
Price/Sales2.70
Price/Book12.10

Competitors

 Today’s
change
Today’s
% change
CELGCelgene-4.73-4.03%
BMYBristol-Myers Squibb-0.79-1.41%
ABBVAbbVie-1.63-2.65%
SNYSanofi-0.14-0.34%
Data as of 4:02pm ET, 12/07/2016

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$0.57
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts


Search for Jobs